Chinese Biopharma Adopts Medidata Cloud in Pediatric Vaccine Program

Article

Applied Clinical Trials

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that its Clinical Cloud platform has been adopted by Walvax Biotechnology.

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that its Clinical Cloud platform has been adopted by Walvax Biotechnology, a biopharmaceutical company in China. Walvax is using the technology to improve data management collection and management in the first multi-center trials of its novel research on a vaccine for pneumococcal conjugate (PCV13).

 

 

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.